REILLY FINANCIAL ADVISORS, LLC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 316 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.

Quarter-by-quarter ownership
REILLY FINANCIAL ADVISORS, LLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$7,0000.0%2200.0%0.00%0.0%
Q3 2021$7,000
-22.2%
2200.0%0.00%0.0%
Q2 2021$9,000
-10.0%
2200.0%0.00%0.0%
Q1 2021$10,000
-16.7%
2200.0%0.00%0.0%
Q4 2020$12,000
-47.8%
220
-54.1%
0.00%
-50.0%
Q3 2020$23,000
+76.9%
479
+117.7%
0.00%0.0%
Q2 2020$13,000
+62.5%
220
+29.4%
0.00%
+100.0%
Q1 2020$8,000
-20.0%
1700.0%0.00%0.0%
Q4 2019$10,000
-47.4%
170
-46.9%
0.00%
-50.0%
Q3 2019$19,000
-9.5%
3200.0%0.00%
-33.3%
Q2 2019$21,000
-19.2%
3200.0%0.00%0.0%
Q1 2019$26,000
+52.9%
3200.0%0.00%
+50.0%
Q4 2018$17,000
-37.0%
320
-38.5%
0.00%
-50.0%
Q3 2018$27,000
+22.7%
5200.0%0.00%
+33.3%
Q2 2018$22,000
-4.3%
5200.0%0.00%0.0%
Q1 2018$23,000
-11.5%
5200.0%0.00%
-25.0%
Q4 2017$26,0000.0%5200.0%0.00%0.0%
Q3 2017$26,0000.0%5200.0%0.00%0.0%
Q2 2017$26,000
+23.8%
5200.0%0.00%
+33.3%
Q1 2017$21,000
-16.0%
5200.0%0.00%
-25.0%
Q4 2016$25,000
+31.6%
5200.0%0.00%
+33.3%
Q3 2016$19,000
+58.3%
5200.0%0.00%
+50.0%
Q2 2016$12,000
-42.9%
5200.0%0.00%
-50.0%
Q1 2016$21,000
-34.4%
5200.0%0.00%
-33.3%
Q4 2015$32,0005200.01%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,541,046$126,5576.89%
M28 Capital Management LP 126,300$4,513,9625.10%
Bellevue Group AG 9,511,900$339,955,3064.93%
Deep Track Capital, LP 2,834,069$101,289,6264.16%
BVF INC/IL 2,560,761$91,521,5983.35%
Sicart Associates LLC 210,698$7,530,3472.93%
Privium Fund Management B.V. 182,773$6,532,3072.19%
Camber Capital Management LP 1,925,000$68,8002.12%
Orbimed Advisors 2,124,500$75,929,6301.49%
SECTOR GAMMA AS 146,441$5,233,8011.27%
View complete list of IONIS PHARMACEUTICALS INC shareholders